282 results
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
29 May 24
Departure of Directors or Certain Officers
7:34am
Spray as core business drivers Sharpened strategy on future growth drivers Leading with integrity through a culture of quality and compliance across our … performance of the Company or any of our businesses, our business strategy, future operations, future financial position, future revenues and earnings, our
8-K
EX-99.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
or any of our businesses, our business strategy, future operations, future financial position, future revenues and earnings, our ability to achieve … capabilities and strategy; and the accuracy of our estimates regarding future revenues, expenses, capital requirements and needs for additional financing
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
provides a summary detailing the strategy for managing expiring ACAM2000 vaccine: Table 6: Strategy for managing expiring ACAM2000 vaccine Task 2 … : [**] Category Proposed Strategy Older lots with [**] since date of manufacture All lots can be managed as having [**] per STN 125158/203 (approved 15 Dec
8-K
EX-99.2
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
, including statements regarding the future performance of the Company or any of our businesses, our business strategy, future operations, future financial … ; the success of our commercialization, marketing and manufacturing capabilities and strategy; and the accuracy of our estimates regarding future revenues
8-K
EX-99.2
8lv40so
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
91ng nn342nbpdadu6vs
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
7vtatff 1n7et2
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
8-K
EX-99.2
f8t8 lirs2
9 Jan 24
Regulation FD Disclosure
8:40am
8-K
EX-99.1
lxogs0fz5hphzzp
28 Nov 23
Other Events
7:15am
8-K
EX-99.1
zx28iiey457 w7m
24 Nov 23
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
7:17am
8-K
EX-99.1
xz1awk5 0cpyerb748
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.2
teez4qs0lhpi2t2dz5hf
8 Nov 23
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
4:21pm